FAKTOR OPTIONSSCHEIN - AMGEN | Real-time BOERSE MUENCHEN 18:45:38 23/05/2024 BST | ||
| 0.58 EUR | +5.45% |
|
| Current month | -95.12% | ||
| 1 month | -95.59% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 23/05/24 | 0.58 | +5.45% |
| 22/05/24 | 0.55 | +5.77% |
| 21/05/24 | 0.52 | -1.89% |
| 20/05/24 | 0.53 | -1.85% |
| 17/05/24 | 0.54 | +3.85% |
Real-time BOERSE MUENCHEN
Last update May 23, 2024 at 06:45 pm
More quotesStatic data
| Product type | Productos Exóticos |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
UniCredit
|
| WKN | HD2VEJ |
| ISIN | DE000HD2VEJ2 |
| Date issued | 21/02/2024 |
| Strike | 361 $ |
| Maturity | Unlimited |
| Parity | 92.04 : 1 |
| Emission price | 10.47 € |
| Emission volume | N/A |
| Settlement | Por diferencias |
| Currency | EUR |
Technical Indicators
| Highest since issue | 15.36 € |
|---|---|
| Lowest since issue | 0.49 € |
| Spread | 0.01 € |
| Spread % | 1.67% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
309.4
USD
Average target price
316.1
USD
Spread / Average Target
+2.15%
- Stock Market
- Certificates
- Certificat
